The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Norfluoxetin     3-phenyl-3-[4- (trifluoromethyl) phenoxy]pro...

Synonyms: Norfluoxetine, CHEMBL1494, SureCN686500, AG-J-73845, NSC-675448, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of NSC675448


Psychiatry related information on NSC675448


High impact information on NSC675448


Biological context of NSC675448


Anatomical context of NSC675448


Associations of NSC675448 with other chemical compounds


Gene context of NSC675448


Analytical, diagnostic and therapeutic context of NSC675448


  1. Fluoxetine disposition and elimination in cirrhosis. Schenker, S., Bergstrom, R.F., Wolen, R.L., Lemberger, L. Clin. Pharmacol. Ther. (1988) [Pubmed]
  2. Fluoxetine pharmacokinetics in pediatric patients. Wilens, T.E., Cohen, L., Biederman, J., Abrams, A., Neft, D., Faird, N., Sinha, V. Journal of clinical psychopharmacology. (2002) [Pubmed]
  3. Dyskinesia with fluoxetine: tardive or late-onset persistent, acute norfluoxetine dyskinesia? Lauterbach, E.C., Shillcutt, S.D. The Journal of clinical psychiatry. (1997) [Pubmed]
  4. Drug-induced long QT syndrome: hERG K(+) channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Rajamani, S., Eckhardt, L.L., Valdivia, C.R., Klemens, C.A., Gillman, B.M., Anderson, C.L., Holzem, K.M., Delisle, B.P., Anson, B.D., Makielski, J.C., January, C.T. Br. J. Pharmacol. (2006) [Pubmed]
  5. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. Levy, N.B., Blumenfield, M., Beasley, C.M., Dubey, A.K., Solomon, R.J., Todd, R., Goodman, A., Bergstrom, R.R. General hospital psychiatry. (1996) [Pubmed]
  6. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? Koran, L.M., Cain, J.W., Dominguez, R.A., Rush, A.J., Thiemann, S. The American journal of psychiatry. (1996) [Pubmed]
  7. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Pinna, G., Costa, E., Guidotti, A. Psychopharmacology (Berl.) (2006) [Pubmed]
  8. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. Amsterdam, J.D., Fawcett, J., Quitkin, F.M., Reimherr, F.W., Rosenbaum, J.F., Michelson, D., Hornig-Rohan, M., Beasley, C.M. The American journal of psychiatry. (1997) [Pubmed]
  9. Recent pharmacologic advances in antidepressant therapy for the elderly. Preskorn, S.H. Am. J. Med. (1993) [Pubmed]
  10. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Traboulsie, A., Chemin, J., Kupfer, E., Nargeot, J., Lory, P. Mol. Pharmacol. (2006) [Pubmed]
  11. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Heikkinen, T., Ekblad, U., Palo, P., Laine, K. Clin. Pharmacol. Ther. (2003) [Pubmed]
  12. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Hendrick, V., Stowe, Z.N., Altshuler, L.L., Mintz, J., Hwang, S., Hostetter, A., Suri, R., Leight, K., Fukuchi, A. Biol. Psychiatry (2001) [Pubmed]
  13. The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. Hendrickse, W.A., Roffwarg, H.P., Grannemann, B.D., Orsulak, P.J., Armitage, R., Cain, J.W., Battaglia, J., Debus, J.R., Rush, A.J. Neuropsychopharmacology (1994) [Pubmed]
  14. Relative rectal bioavailability of fluoxetine in normal volunteers. Teter, C.J., Phan, K.L., Cameron, O.G., Guthrie, S.K. Journal of clinical psychopharmacology. (2005) [Pubmed]
  15. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Leonard, B.E. Drugs (1992) [Pubmed]
  16. Human cytochromes mediating N-demethylation of fluoxetine in vitro. von Moltke, L.L., Greenblatt, D.J., Duan, S.X., Schmider, J., Wright, C.E., Harmatz, J.S., Shader, R.I. Psychopharmacology (Berl.) (1997) [Pubmed]
  17. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Kennard, L.E., Chumbley, J.R., Ranatunga, K.M., Armstrong, S.J., Veale, E.L., Mathie, A. Br. J. Pharmacol. (2005) [Pubmed]
  18. Effect of fluoxetine on rat liver mitochondria. Souza, M.E., Polizello, A.C., Uyemura, S.A., Castro-Silva, O., Curti, C. Biochem. Pharmacol. (1994) [Pubmed]
  19. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Czachura, J.F., Rasmussen, K. Naunyn Schmiedebergs Arch. Pharmacol. (2000) [Pubmed]
  20. An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats. Lightowler, S., Wood, M., Brown, T., Glen, A., Blackburn, T., Tulloch, I., Kennett, G. Eur. J. Pharmacol. (1996) [Pubmed]
  21. Pharmacokinetics of the newer antidepressants: clinical relevance. DeVane, C.L. Am. J. Med. (1994) [Pubmed]
  22. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Pälvimäki, E.P., Roth, B.L., Majasuo, H., Laakso, A., Kuoppamäki, M., Syvälahti, E., Hietala, J. Psychopharmacology (Berl.) (1996) [Pubmed]
  23. In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain. Komoroski, R.A., Newton, J.E., Cardwell, D., Sprigg, J., Pearce, J., Karson, C.N. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. (1994) [Pubmed]
  24. Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism. Brøsen, K., Skjelbo, E. British journal of clinical pharmacology. (1991) [Pubmed]
  25. Monoamine oxidase A inhibition by fluoxetine: an in vitro and in vivo study. Mukherjee, J., Yang, Z.Y. Synapse (1999) [Pubmed]
  26. Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine. Ring, B.J., Eckstein, J.A., Gillespie, J.S., Binkley, S.N., VandenBranden, M., Wrighton, S.A. J. Pharmacol. Exp. Ther. (2001) [Pubmed]
  27. Differences in interactions of SSRIs. Brøsen, K. International clinical psychopharmacology. (1998) [Pubmed]
  28. Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. Rasmussen, B.B., Maënpää, J., Pelkonen, O., Loft, S., Poulsen, H.E., Lykkesfeldt, J., Brøsen, K. British journal of clinical pharmacology. (1995) [Pubmed]
  29. Effect of alosetron on the pharmacokinetics of fluoxetine. D'Souza, D.L., Dimmitt, D.C., Robbins, D.K., Nezamis, J., Simms, L., Koch, K.M. Journal of clinical pharmacology. (2001) [Pubmed]
  30. Effects of CYP2C19 genotype and CYP2C9 on fluoxetine N-demethylation in human liver microsomes. Liu, Z.Q., Shu, Y., Huang, S.L., Wang, L.S., He, N., Zhou, H.H. Acta Pharmacol. Sin. (2001) [Pubmed]
  31. Fluoxetine kinetics and protein binding in normal and impaired renal function. Aronoff, G.R., Bergstrom, R.F., Pottratz, S.T., Sloan, R.S., Wolen, R.L., Lemberger, L. Clin. Pharmacol. Ther. (1984) [Pubmed]
  32. Fluoxetine, an antidepressant, and norfluoxetine, its metabolite, determined by HPLC with a C8 column and ultraviolet detection. el Maanni, A., Combourieu, I., Bonini, M., Creppy, E.E. Clin. Chem. (1993) [Pubmed]
  33. Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection. Nash, J.F., Bopp, R.J., Carmichael, R.H., Farid, K.Z., Lemberger, L. Clin. Chem. (1982) [Pubmed]
WikiGenes - Universities